Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia
Chronic inflammation is one of the main features of cancer cachexia. Experimental and
clinical studies showed that cyclooxygenase-2 inhibitors, such as celecoxib, may be …
clinical studies showed that cyclooxygenase-2 inhibitors, such as celecoxib, may be …
Molecular targeted therapies in adrenal, pituitary and parathyroid malignancies
A Angelousi, GK Dimitriadis, G Zografos… - Endocrine-Related …, 2017 - erc.bioscientifica.com
Tumourigenesis is a relatively common event in endocrine tissues. Currently, specific
guidelines have been developed for common malignant endocrine tumours, which also …
guidelines have been developed for common malignant endocrine tumours, which also …
Cyclooxygenase-2 inhibitors and antioxidants in the treatment of cachexia
G Mantovani, C Madeddu - Current Opinion in Supportive and …, 2008 - journals.lww.com
Fairly advanced clinical data on efficacy of cyclooxygenase-2 inhibitors and antioxidants in
advanced cancer patients are promising, but the best way to administer and combine them …
advanced cancer patients are promising, but the best way to administer and combine them …
Brassinin alleviates cancer cachexia by suppressing diverse inflammatory mechanisms in mice
Cancer cachexia is a multifactorial condition that contributes to the death of about 20% of
cancer patients. It has the potential to cause weight loss, reduction in muscle mass, and loss …
cancer patients. It has the potential to cause weight loss, reduction in muscle mass, and loss …
A diet rich in fish oil and leucine ameliorates hypercalcemia in tumour-induced cachectic mice
Background: Dietary supplementation with leucine and fish oil rich in omega-3 fatty acids
docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) has previously been shown …
docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) has previously been shown …
Cyclooxygenase and CD147 expression in oral squamous cell carcinoma patient samples and cell lines
WHS Nasry, H Wang, K Jones, M Tesch… - Oral Surgery, Oral …, 2019 - Elsevier
Objectives In oral squamous cell carcinoma (OSCC), cyclooxygenases (COX-1 and COX-2)
contribute to inflammation, and cluster of differentiation factor 147 (CD147) contributes to …
contribute to inflammation, and cluster of differentiation factor 147 (CD147) contributes to …
[PDF][PDF] The Effect of Thalidomide on Cachexia in Upper Gastrointestinal Cancer
S Green - 2015 - core.ac.uk
Progress made in the palliation of those with terminal cancers has allowed most symptoms
to be controlled if not completely alleviated. For many in this situation now, the most …
to be controlled if not completely alleviated. For many in this situation now, the most …
Tratamiento Farmacológico del Sindrome Caquexia-Anorexia-Cáncer.
NE Suárez Nieto, P Bonilla, M Hidalgo - Informe Medico, 2012 - search.ebscohost.com
En el síndrome caquexia-anorexia-cáncer (Sx CAC) hay una incrementada demanda
calórica, expresión de sustancias anorexigénicas endógenas, cambios hormonales y …
calórica, expresión de sustancias anorexigénicas endógenas, cambios hormonales y …